1-(3-Chlorophenyl)piperazine monohydrochloride

HCID 25681CAS 13078-15-4

基本情報

標準SMILES: Cl.Clc1cccc(N2CCNCC2)c1
InChIKey: MHXPYWFZULXYHT-UHFFFAOYSA-N
分子式: C10H14Cl2N2
平均分子量: 233.13 g/mol
単同位体質量: 232.05340381

名称と識別子

優先名称: 1-(3-Chlorophenyl)piperazine monohydrochloride
IUPAC: 1-(3-chlorophenyl)piperazine;hydrochloride

名称と別名

1-(3-Chlorophenyl)piperazine monohydrochlorideRefChem:743161-(3-Chlorophenyl)piperazine hydrochloride13078-15-465369-76-81-(M-CHLOROPHENYL)PIPERAZINE HYDROCHLORIDE1-(3-Chlorophenyl)piperazinium chloride1-(m-Chlorophenyl)piperazine HClPiperazine, 1-(3-chlorophenyl)-, monohydrochloride1-(3-Chlorophenyl)piperazine HCl1-(3-chlorophenyl)piperazine;hydrochloride7IM2GS7ILV

名称をさらに表示

m-CPP hydrochlorideNSC-134746Chlorophenyl Piperazine Hydrochloride SaltTrazodone Impurity 61-(3-Chlorophenyl)-piperazine.HCl(3-chlorophenyl)piperazine, chloridem-chlorophenylpiperazine hydrochlorideSMR000875230

データベース識別子

CAS: 13078-15-4、51639-49-7、65369-76-8
PubChem CID: 25681
DTXSID: DTXSID40896823
ChEMBL: CHEMBL1256321
UNII: 7IM2GS7ILV
EC Number: 235-976-9、265-718-0

物性

構造計算による物性

極性表面積: 15.3 Å²
水素結合供与体数: 2
水素結合受容体数: 2
回転可能結合数: 1
重原子数: 14
形式電荷: 0
複雑度: 157

実験および物理化学的性質

Solubility>35 [ug/mL] (The mean of the results at pH 7.4)

安全と法規制

GHS分類

GHS Classification · 6 件

Warning

H302 (97.7%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 43 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

危険有害性情報

Hazard Classes and Categories · 2 件

Acute Tox. 4 (97.7%)

Acute Tox. 3 (100%)

化学と産業

薬理情報

MeSH Pharmacological ClassificationEndogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS.